The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effectiveness of gemcitabine and capecitabine in advanced colorectal cancer patients: A retrospective analysis.
Mercedes Salgado
No relevant relationships to disclose
Margarita Reboredo
No relevant relationships to disclose
Ana Medina
No relevant relationships to disclose
Guillermo Quintero
No relevant relationships to disclose
Maria Luz Pellon
No relevant relationships to disclose
Carlos Romero Reinoso
No relevant relationships to disclose
Mónica Jorge
No relevant relationships to disclose
Ana Fernandez-Montes
No relevant relationships to disclose